Journal of Chemotherapy

Journal of Chemotherapy
期刊缩写:
J. Chemother.
影响因子:
1.9
ISSN:
print: 1120-009X
on-line: 1973-9478
研究领域:
医学-药学
创刊年份:
1989年
h-index:
45
自引率:
0.00%
Gold OA文章占比:
4.91%
原创研究文献占比:
85.19%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore)
期刊介绍英文:
The Journal of Chemotherapy is an international multidisciplinary journal committed to the rapid publication of high quality, peer-reviewed, original research on all aspects of antimicrobial and antitumor chemotherapy. The Journal publishes original experimental and clinical research articles, state-of-the-art reviews, brief communications and letters on all aspects of chemotherapy, providing coverage of the pathogenesis, diagnosis, treatment, and control of infection, as well as the use of anticancer and immunomodulating drugs. Specific areas of focus include, but are not limited to: · Antibacterial, antiviral, antifungal, antiparasitic, and antiprotozoal agents; · Anticancer classical and targeted chemotherapeutic agents, biological agents, hormonal drugs, immunomodulatory drugs, cell therapy and gene therapy; · Pharmacokinetic and pharmacodynamic properties of antimicrobial and anticancer agents; · The efficacy, safety and toxicology profiles of antimicrobial and anticancer drugs; · Drug interactions in single or combined applications; · Drug resistance to antimicrobial and anticancer drugs; · Research and development of novel antimicrobial and anticancer drugs, including preclinical, translational and clinical research; · Biomarkers of sensitivity and/or resistance for antimicrobial and anticancer drugs; · Pharmacogenetics and pharmacogenomics; · Precision medicine in infectious disease therapy and in cancer therapy; · Pharmacoeconomics of antimicrobial and anticancer therapies and the implications to patients, health services, and the pharmaceutical industry.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
3.70.4390.531
学科
排名
百分位
大类:Medicine
小类:Pharmacology (medical)
139 / 272
49%
大类:Medicine
小类:Infectious Diseases
181 / 344
47%
大类:Medicine
小类:Oncology
228 / 404
43%
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
186 / 313
40%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
4区 医学
4区 传染病学 INFECTIOUS DISEASES
4区 肿瘤学 ONCOLOGY
4区 药学 PHARMACOLOGY & PHARMACY
WOS期刊分区
学科分类
Q3INFECTIOUS DISEASES
Q3ONCOLOGY
Q3PHARMACOLOGY & PHARMACY
历年影响因子
2015年1.3330
2016年1.5770
2017年1.4900
2018年1.5990
2019年1.6610
2020年1.7140
2021年2.3850
2022年1.8000
2023年1.9000
历年发表
2012年68
2013年115
2014年69
2015年19
2016年135
2017年51
2018年40
2019年62
2020年86
2021年121
2022年144
投稿信息
出版周期:
Bimonthly
出版语言:
English
出版国家(地区):
ITALY
审稿时长:
6-12 weeks
出版商:
Maney Publishing
编辑部地址:
ESIFT SRL, VIA CARLO DEL GRECO 36,, FLORENCE, ITALY, 50141

Journal of Chemotherapy - 最新文献

Clinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC).

Pub Date : 2024-12-01 DOI: 10.1080/1120009X.2024.2308978 Thierry Landre, Christos Chouaïd, Nassyma Sadaoui, Djamila Bouharati, Chérifa Taleb

Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents.

Pub Date : 2024-12-01 DOI: 10.1080/1120009X.2023.2300217 Mohammad Amin Manavi, Mohammad Hosein Fathian Nasab, Razieh Mohammad Jafari, Ahmad Reza Dehpour

Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma.

Pub Date : 2024-12-01 DOI: 10.1080/1120009X.2024.2308975 Xiang-Di Tan, Cui-Fang Luo, Si-Yu Liang
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信